OMass Technologies
Srinath Krishnamurthy has extensive work experience in various research roles. From 2022 onwards, they worked at OMass Therapeutics as a Senior Scientist. Prior to that, they served as a Senior Scientist at the same company from 2022 to 2023. From 2016 to 2021, Srinath worked as a Postdoctoral Research Fellow at KU Leuven. In addition, they were a Marie Skłodowska-Curie Fellow at Research Foundation Flanders - FWO from 2016 to 2019. Srinath also held positions at the National University of Singapore, including Postdoctoral Research Fellow from 2015 to 2015, Research Assistant from 2013 to 2014, and Graduate Scholar from 2009 to 2014.
Srinath Krishnamurthy completed a Bachelor of Technology (B.Tech.) degree in Industrial Biotechnology at Anna University from 2005 to 2009. Later, from 2009 to 2014, they pursued a Doctor of Philosophy (PhD) degree in Biochemistry, Biophysics, and Molecular Biology at the National University of Singapore.
OMass Technologies
1 followers
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.